April 25, 2008 / 11:18 AM / 9 years ago

QLT pushed to loss on weak Visudyne sales

TORONTO (Reuters) - QLT Inc QLT.TO QLTI.O said on Friday it slipped to a first-quarter loss, hurt by a restructuring charge and slumping sales of its Visudyne anti-blindness treatment.

The company said it lost $10.5 million, or 14 cents a share in the quarter ended March 31, compared with a profit of $4.9 million, or 6 cents a share, in the same period last year.

Reporting by Scott Anderson; Editing by Ka Yan Ng

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below